,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-11-20 01:03:00,The Zacks Research Daily presents the best research output of our analyst team.,0.6325156092643738,0.012341027148067951,0.35514333844184875,positive,0.6201745867729187
1,2017-11-20 01:03:00,"Today's Research Daily features new research reports on 16 major stocks, including Walmart (WMT), NVIDIA (NVDA) and Procter & Gamble (PG).",0.039597634226083755,0.008188753388822079,0.9522136449813843,neutral,0.0314088799059391
2,2017-11-20 01:03:00,These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.,0.054846275597810745,0.007339245639741421,0.937814474105835,neutral,0.04750702902674675
3,2017-11-20 01:03:00,"You can see all of today's research reports here >>>

Buy-rated Walmart 's shares have been strong performers lately, with the stock up +24.1% over the last six months, outperforming the S&P 500's +7.8% gain in the same time period.",0.9495315551757812,0.027619939297437668,0.02284843660891056,positive,0.9219115972518921
4,2017-11-20 01:03:00,The Zacks analyst likes Walmart's solid earnings and comps record.,0.8934922218322754,0.02234768122434616,0.08416007459163666,positive,0.8711445331573486
5,2017-11-20 01:03:00,"The company has been gaining from constant e-commerce initiatives, like buyouts, alliances, and improved delivery systems.",0.9398477077484131,0.014712118543684483,0.045440174639225006,positive,0.925135612487793
6,2017-11-20 01:03:00,"These trends, along with solid traffic drove Walmart's third-quarter fiscal 2018 performance, wherein both earnings and revenues rose year over year and beat estimates.",0.9513853192329407,0.02412775717675686,0.024486850947141647,positive,0.9272575378417969
7,2017-11-20 01:03:00,"Notably, this marked Walmart's ninth and 13th straight quarter of positive earnings surprise and U.S. comps growth, respectively.",0.9436555504798889,0.02833562158048153,0.02800881490111351,positive,0.9153199195861816
8,2017-11-20 01:03:00,"Also, the company's international performance gained from strength in food categories.",0.9526792168617249,0.01625077798962593,0.031069951131939888,positive,0.936428427696228
9,2017-11-20 01:03:00,All these factors encouraged management to raise its view.,0.6353973150253296,0.015582949854433537,0.34901976585388184,positive,0.6198143362998962
10,2017-11-20 01:03:00,"However, stiff competition from brick and mortar and online retailers remains a concern.",0.07385363429784775,0.6273887157440186,0.2987576425075531,negative,-0.5535351037979126
11,2017-11-20 01:03:00,"Also, macroeconomic woes like volatile consumer spending poses threats.",0.026929544284939766,0.873023509979248,0.10004692524671555,negative,-0.8460939526557922
12,2017-11-20 01:03:00,(You can read the full research report on Walmart here >>> ).,0.012951191514730453,0.014087408781051636,0.97296142578125,neutral,-0.0011362172663211823
13,2017-11-20 01:03:00,"Shares of Strong Buy-rated NVIDIA have surged over the last year, gaining in excess of +127.4% versus the Zacks Semiconductor - General industry's +52% gain.",0.9556521773338318,0.024270182475447655,0.020077591761946678,positive,0.9313820004463196
14,2017-11-20 01:03:00,NVIDIA posted impressive third-quarter fiscal 2018 results and provided encouraging fourth quarter revenue guidance.,0.9508755803108215,0.020410330966114998,0.028714098036289215,positive,0.9304652214050293
15,2017-11-20 01:03:00,"Also, the company registered year-over-year growth on both counts, primarily due to growth across all its four platforms.",0.9418274164199829,0.014442743733525276,0.04372981935739517,positive,0.9273846745491028
16,2017-11-20 01:03:00,Better-than-expected demand for gaming chips helped the company post encouraging results.,0.951262891292572,0.021772006526589394,0.026965158060193062,positive,0.929490864276886
17,2017-11-20 01:03:00,"The Zacks analyst likes NVIDIA's sustained efforts toward attaining robust position in several emerging industries such as Artificial Intelligence (AI), deep learning and driverless cars.",0.9288964867591858,0.01365557312965393,0.05744791030883789,positive,0.9152408838272095
18,2017-11-20 01:03:00,NVIDIA's innovative product pipeline and strength in gaming and high-end notebook GPUs remain the positives.,0.8676509261131287,0.013265078887343407,0.11908397078514099,positive,0.8543858528137207
19,2017-11-20 01:03:00,"The company's focus on GRID platforms can increase GPU adoption in data centers, giving it an advantage against its competitors.",0.9487294554710388,0.01761609874665737,0.033654455095529556,positive,0.9311133623123169
20,2017-11-20 01:03:00,(You can read the full research report on NVIDIA here >>> ).,0.014068027026951313,0.014515203423798084,0.971416711807251,neutral,-0.00044717639684677124
21,2017-11-20 01:03:00,Procter & Gamble 's shares have underperformed the Zacks Soap and Cleaning Materials industry so far this year (+5.2% vs. +14.2%).,0.15801914036273956,0.8163698315620422,0.025611041113734245,negative,-0.6583507061004639
22,2017-11-20 01:03:00,"P&G reported first-quarter fiscal 2018 results, wherein earnings and revenues surpassed expectations.",0.9338017106056213,0.019970804452896118,0.04622752591967583,positive,0.9138308763504028
23,2017-11-20 01:03:00,Adjusted earnings increased 6% from the year-ago level aided by productivity cost savings.,0.959068775177002,0.022334743291139603,0.018596602603793144,positive,0.9367340207099915
24,2017-11-20 01:03:00,"Overall organic sales were up 1%, comprising 1% volume growth despite decelerating market growth and a 30 bps headwind from natural disasters.",0.9557961225509644,0.021605050191283226,0.022598840296268463,positive,0.9341910481452942
25,2017-11-20 01:03:00,"The Zacks analyst likes the company's focus on balanced growth through improved product, packaging, and marketing initiatives and its productivity cost saving plan.",0.9194074273109436,0.015606747940182686,0.06498580425977707,positive,0.9038006663322449
26,2017-11-20 01:03:00,"However, core gross and operating margin weakness was notable in the quarter that decreased 40 bps each.",0.019675541669130325,0.9694420099258423,0.010882440954446793,negative,-0.9497664570808411
27,2017-11-20 01:03:00,"Lower pricing, higher commodity costs, increased competition and an unfavorable mix continued to hurt profitability.",0.017988454550504684,0.9693356156349182,0.012675917707383633,negative,-0.9513471722602844
28,2017-11-20 01:03:00,"Again, decelerating organic sales growth in developed and developing markets raise concerns.",0.15144506096839905,0.7459818124771118,0.10257312655448914,negative,-0.5945367813110352
29,2017-11-20 01:03:00,(You can read the full research report on Procter & Gamble here >>> ).,0.013788774609565735,0.010992237366735935,0.9752189517021179,neutral,0.0027965372428297997
30,2017-11-20 01:03:00,"Other noteworthy reports we are featuring today include Mondelez (MDLZ), Phillips 66 (PSX) and AstraZeneca (AZN).",0.048702746629714966,0.004986312706023455,0.9463108777999878,neutral,0.0437164343893528
31,2017-11-20 01:03:00,Looking for Stocks with Skyrocketing Upside?,0.09469357132911682,0.09826507419347763,0.807041347026825,neutral,-0.0035715028643608093
32,2017-11-20 01:03:00,Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.,0.41462862491607666,0.01087752915918827,0.5744938254356384,neutral,0.40375110507011414
33,2017-11-20 01:03:00,"Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021.",0.8838319182395935,0.03136736899614334,0.08480073511600494,positive,0.8524645566940308
34,2017-11-20 01:03:00,"Early investors stand to make a killing, but you have to be ready to act and know just where to look.",0.19955629110336304,0.018484661355614662,0.781959056854248,neutral,0.18107162415981293
35,2017-11-20 01:03:00,"See the pot trades we're targeting>>

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings.",0.08856207132339478,0.007175061851739883,0.904262900352478,neutral,0.08138701319694519
36,2017-11-20 01:03:00,He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trendsand Earnings Preview reports.,0.025165576487779617,0.008906112052500248,0.9659282565116882,neutral,0.016259465366601944
37,2017-11-20 01:03:00,"If you want an email notification each time Sheraz publishes a new article, please click here>>>

Ross Stores boasts impressive comparable sales run.",0.9179943203926086,0.018537750467658043,0.06346799433231354,positive,0.8994565606117249
38,2017-11-20 01:03:00,"Per the Zacks analyst, the company's better price management, merchandise, cost containment and operational initiatives should drive sales.",0.9450442790985107,0.015291695483028889,0.03966411203145981,positive,0.9297525882720947
39,2017-11-20 01:03:00,"Exelon (EXC) to Gain from $20B Investments and Cost Savings

The Zacks analyst believes Exelon will gain from its continuous investment to strengthen its regulated assets, while its cost savings initiatives will boost its margins.",0.9545623660087585,0.016494153067469597,0.02894352748990059,positive,0.9380682110786438
40,2017-11-20 01:03:00,The covering analyst stresses that Power Brands has significantly contributed to Mondelez's revenue growth.,0.9052398800849915,0.012016967870295048,0.08274313807487488,positive,0.8932229280471802
41,2017-11-20 01:03:00,"However, the company's volume trends remain weak owing to sluggish demand.",0.01836145669221878,0.9301948547363281,0.05144370347261429,negative,-0.9118334054946899
42,2017-11-20 01:03:00,The Zacks analyst believes TD Ameritrade is poised to growth through improving trading activities as DARTs continue to rise.,0.949958324432373,0.014803798869252205,0.0352378711104393,positive,0.9351544976234436
43,2017-11-20 01:03:00,"Moreover, increase in revenue and easing margin pressure is favorable.",0.9493990540504456,0.02029460296034813,0.030306318774819374,positive,0.9291044473648071
44,2017-11-20 01:03:00,"Per the Zacks analyst, AstraZeneca's newer drugs like Tagrisso and Brilinta should keep boosting the top line.",0.9200382828712463,0.0189594104886055,0.06100231781601906,positive,0.9010788798332214
45,2017-11-20 01:03:00,"Rising debt load and declining cash balance are serious concerns, per the Zacks analyst.",0.021387431770563126,0.9395074248313904,0.039105117321014404,negative,-0.9181199669837952
46,2017-11-20 01:03:00,"Per the Zacks analyst, CME Group gains from higher clearing and transaction fees and volume growth.",0.9565860033035278,0.021313613280653954,0.02210037223994732,positive,0.9352723956108093
47,2017-11-20 01:03:00,"Per the Zacks analyst, Netflix continues to benefit from its ever expanding portfolio of original content.",0.9417499899864197,0.014563688077032566,0.04368629679083824,positive,0.9271863102912903
48,2017-11-20 01:03:00,Emphasis on regional content will boost its international subscriber base.,0.9538124799728394,0.018099091947078705,0.028088511899113655,positive,0.9357134103775024
49,2017-11-20 01:03:00,The Zacks analyst stresses that RH's membership business model and waterworks acquisition has enhanced the company's brand value and profitability.,0.9521954655647278,0.015553602017462254,0.032251011580228806,positive,0.9366418719291687
50,2017-11-20 01:03:00,The Zacks analyst appreciates the strong growth in advertising and affiliate revenues on the international front.,0.925207257270813,0.01682763732969761,0.05796514078974724,positive,0.9083796143531799
51,2017-11-20 01:03:00,Efforts to reward shareholders and bring down its debt levels also raise optimism.,0.9117730855941772,0.028746021911501884,0.05948081985116005,positive,0.8830270767211914
52,2017-11-20 01:03:00,"Per the Zacks analyst, Zimmer Biomet is grappling with supply delays, leading to the inability to recapture lost customers and gain new ones.",0.027087558060884476,0.9552926421165466,0.017619803547859192,negative,-0.9282050728797913
53,2017-11-20 01:03:00,Soft domestic market conditions is another concern.,0.027094898745417595,0.03769497573375702,0.9352100491523743,neutral,-0.010600076988339424
54,2017-11-20 01:03:00,"Poor operating history and frequent unplanned outages in the Syncrude project have hiked its near-term operating costs, which might hurt Suncor's earnings.",0.021057698875665665,0.9677802324295044,0.011162039823830128,negative,-0.9467225074768066
55,2017-11-20 01:03:00,"Per the Zacks analyst, ITT's growth might be hampered due to weak mining activity, restrained client spending and softness in aerospace & defense market.",0.01994759775698185,0.9636709094047546,0.01638140343129635,negative,-0.9437233209609985
56,2017-11-20 01:03:00,"Also, rising commodity costs remain a concern.",0.06357727944850922,0.25222247838974,0.6842002272605896,neutral,-0.18864519894123077
57,2017-11-20 01:03:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
58,2017-11-20 01:03:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
59,2017-11-20 01:03:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
60,2017-11-20 01:03:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.015637893229722977,0.9741575717926025,neutral,-0.0054333265870809555
